BIOMEX at EACR 2026!
We’re excited to be attending the European Association for Cancer Research (EACR) Congress 2026 in Hashtag#Budapest from June 8–11, 2026! Visit us at Booth #74 and meet our experts on site: Dr. Susanna Maria Lissek & Dr. Robert Rusch We are looking forward to many inspiring conversations about your cancer research projects and discussing how Read More
Only a few days to go until CIMT 2026!
Only a few days to go until CIMT 2026! At BIOMEX, we support personalized immunotherapy through comprehensive in-house donor characterization and assay capabilities, from immune profiling to functional testing. Visit us at Booth #5 and connect with our Sales Experts, Dr. Robert Rusch and Melosha Puspathasan, to discuss how BIOMEX can support your immunotherapy and Read More
Central BioHub continues under BIOMEX
Central BioHub continues with a clear focus on human biospecimens. As part of the insolvency proceedings of Central BioHub GmbH, BIOMEX has acquired the trademark rights to “Central BioHub.” Today, the Central BioHub brand stands for reliable access to high quality human biospecimens, supported by BIOMEX’s established infrastructure. Customers can source #wholeblood, #plasma, #serum, #CSF, Read More
BIOMEX at the DGMB Annual Meeting 2026 in Heidelberg
From April 15–17, BIOMEX will be participating in the annual meeting of the Deutsche Gesellschaft für Matrixbiologie (DGMB) e.V. in Heidelberg – contributing to the scientific dialogue shaping the future of matrix biology. A key highlight of the event will be the presentation by our scientist Dr. Jasmina Paluncic, taking place on Wednesday, April 15th Read More
BIOMEX at CACLP 2026
What an inspiring few days at CACLP 2026! BIOMEX was delighted to be part of this year’s event and to connect with the global diagnostics community. At our booth, we had the pleasure of meeting numerous partners, customers, and new contacts, engaging in meaningful discussions about current challenges and future opportunities in the diagnostics field. Read More
BIOMEX Exhibits at CACLP 2026
BIOMEX is pleased to announce that we will be exhibiting at CACLP 2026, taking place March 21–23, 2026, in China. We will be present together with our sister company IVD TRIALS. Visitors will have the opportunity to learn more about BIOMEX’s high-quality biospecimens as well as the comprehensive IVDR expertise and validation studies offered by Read More
Measurement of Typhi Vi antibodies
In June 2018, a peer-reviewed study investigating Typhi Vi IgG antibodies as a measure of adaptive immunity in immunodeficiency research utilised serum samples collected through BIOMEX donor centres in Germany. The study analysed 215 well-characterised blood donor serum samples, collected with informed consent and ethical approval (IRB no. 05142). Donors were stringently screened to exclude Read More
Research publication using BIOMEX PBMCs
TBET-expressing Th1 CD4+ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ-TCL1 mice A publication titled “TBET-expressing Th1 CD4+ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ-TCL1 mice” reports on immune cell dynamics in chronic lymphocytic leukaemia. The study utilised BIOMEX-provided PBMCs as part of its Read More
MEDICA 2025
Thank you for an inspiring week MEDICA 2025 was a great success for us and an important moment in presenting our capabilities to an international audience. Our new booth design immediately drew attention and gave us the ideal setting to showcase our products, discuss current projects and highlight how we support partners in diagnostics, pharma Read More
MEDICA 2025 is just around the corner!
We’re excited to be back at MEDICA 2025 and can’t wait to catch up with partners, customers, and colleagues from around the world.Together with our sister company IVD TRIALS, we’re ready to share our expertise and support you in your next project. BIOMEX stands for high-quality human biospecimens for research and diagnostics, while IVD TRIALS Read More